Skip to main content
All lobbying filings

ARTEMIS POLICY GROUP LLC

Lobbying for SICKLE CELL DISEASE ASSOCIATION OF AMERICA · national organization dedicated to supporting people living with sickle cell disease

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · Maryland · House · Senate · $20,000.00 income · posted Jul 20, 2026

Official filing document

 Bills named in this filing 3
  • S 721
    Sickle Cell Disease Comprehensive Care Act
  • HR 5178
    Sickle Cell Disease Comprehensive Care Act
  • HR 1
    For the People Act of 2021
 Lobbying activity 4
Health Issues

Potential legislation on hospital emergency department care of people with sickle cell disease Education and support for Congressional Sickle Cell Disease Caucus

Medicare/Medicaid

Engagement with the Center for Medicare and Medicaid Innovation on the Cell & Gene Therapy Access Model Sickle Cell Disease Comprehensive Care Act (S. 721/H.R. 5178) Medicaid eligibility and coverage for needed services for people living with sickle cell disease Implementation of Medicaid Community Engagement provisions of HR 1

Budget/Appropriations

Funding for federal sickle cell disease programs Funding and staffing for the CDC Division of Blood Disorders and Public Health Genomics Funding for and continuation of HRSAs Sickle Cell Disease Newborn Screening Follow Up Program FY27 House and Senate Labor-HHS Appropriations

Insurance

Implementation of H.R. 1, One Big Beautiful Bill Act Policies related to Medicaid and ACA Marketplace plans

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem